Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
April 8, 2026
Host Jon Najarian interviews CEO, Paul Hickey. He details how Reshape Lifesciences is finding the best approach to treat obesity with a less invasive surgical process.